Fat blend
Patent 7045143 Issued on May 16, 2006. Estimated Expiration Date: 
December 22, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
December 22, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesNutritional product for pulmonary patients Nutrition Method for the prevention and treatment of cachexia and anorexia Patent #: 6077828 InventorsAssigneeApplicationNo. 09581520 filed on 12/22/1998US Classes:424/439, Food or edible as carrier for pharmaceutical424/400, PREPARATIONS CHARACTERIZED BY SPECIAL PHYSICAL FORM424/484, Matrices426/531, PRODUCTS PER SE, OR PROCESSES OF PREPARING OR TREATING COMPOSITIONS INVOLVING CHEMICAL REACTION BY ADDITION, COMBINING DIVERSE FOOD MATERIAL, OR PERMANENT ADDITIVE426/580, Basic ingredient lacteal derived other than butter substitute in emulsion form426/601, Fat or oil is basic ingredient other than butter in emulsion form426/648, Nutritional or dietetic supplement, including table salt426/72, PRODUCT WITH ADDED VITAMIN OR DERIVATIVE THEREOF FOR FORTIFICATION424/523Fish oil or solidified form thereofExaminersPrimary: Azpuru, CarlosAttorney, Agent or FirmForeign Patent References
International ClassesA61K 47/44A61K 9/14 A23D 9/013 A23D 7/01 A23C 9/154 AbstractThe invention relates to an oil, fat and/or lecithin-based fat blend containing polyunsaturated fatty acids. The inventive fat blend is characterized in that the fatty acids gamma-linolenic, stearidonic acid and eicosapentaenoic together make up 10 to 500 mg/g total fatty acids. The gamma-linolenic and eicosapentaenoic acids each represent 20 to 50 wt. % and the stearidonic acid represents 15 to 50 wt. % of the sum of these three fatty acids. The inventive fat blend can be incorporated into a dietetic or a pharmaceutical product, especially a dietetic food, and can be used especially for administering to patients suffering from chronic/inflammatory diseases, disorders of the lipid metabolism, a weakened immune function and/or a restricted lipolytic capacity of the gastrointestinal tract.Field of SearchPREPARATIONS CHARACTERIZED BY SPECIAL PHYSICAL FORMFood or edible as carrier for pharmaceutical Matrices PRODUCTS PER SE, OR PROCESSES OF PREPARING OR TREATING COMPOSITIONS INVOLVING CHEMICAL REACTION BY ADDITION, COMBINING DIVERSE FOOD MATERIAL, OR PERMANENT ADDITIVE Basic ingredient lacteal derived other than butter substitute in emulsion form Fat or oil is basic ingredient other than butter in emulsion form Nutritional or dietetic supplement, including table salt | |
